Biological E. Limited Receives Authorization to Manufacture and Market the 14-valent Vaccine against Streptococcus pneumoniae Infection in India
source https://www.pharmatutor.org/pharma-news/2022/dcgi-approves-be-14-valent-pneumococcal-conjugate-vaccine
No comments:
Post a Comment